DM
DEPPE MICHAEL J
Vice-Président, Contrôleur Corporatif et CAO
OtherM
Insider track record
ExecutiveAcross 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by DEPPE MICHAEL J, Vice-Président, Contrôleur Corporatif et CAO. Officer active across 1 company, notably Quest Diagnostics INC. Cumulatively, 19 filings have been recorded. Activity tracked since 18 May 2021. The latest transaction was filed on 3 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations19 total
1,692 shares@ US$173.7413.0% of flowCommon StockSEC:0001022079-25-000092:0
88 shares@ US$171.750.7% of flowCommon StockSEC:0001022079-25-000070:0
99 shares@ US$169.710.7% of flowCommon StockSEC:0001022079-25-000050:0
454 shares0Common StockSEC:0001022079-25-000031:0
8,635 shares@ US$71.1726.0% of flowCommon StockSEC:0001022079-24-000204:0
52 shares@ US$126.360.3% of flowCommon StockSEC:0001022079-24-000078:0
1,689 shares@ US$125.029.0% of flowCommon StockSEC:0001022079-24-000062:0
89 shares@ US$125.020.5% of flowCommon StockSEC:0001022079-24-000049:0
558 shares0Common StockSEC:0001022079-24-000028:0
1,918 shares@ US$147.8612.3% of flowCommon StockSEC:0001022079-23-000067:0
68 shares@ US$140.690.4% of flowCommon StockSEC:0001022079-23-000046:0
188 shares@ US$147.861.2% of flowCommon StockSEC:0001022079-23-000033:0
9,126 shares@ US$52.16521.8% of flowCommon StockSEC:0001022079-22-000143:0
8 shares@ US$136.980.0000% mcap0.3% of flowCommon StockSEC:0001022079-22-000097:0
2,310 shares@ US$130.090.0014% mcap91.0% of flowCommon StockSEC:0001022079-22-000064:0
549 shares0Common StockSEC:0001022079-22-000035:0
219 shares@ US$130.090.0001% mcap8.3% of flowCommon StockSEC:0001022079-22-000019:0
5 shares@ US$136.600.0000% mcap0.2% of flowCommon StockSEC:0001022079-21-000079:0
5 shares@ US$136.600.2% of flowCommon StockSEC:0001022079-21-000079
About DEPPE MICHAEL J
Michael J. Deppe is VP, Corp. Controller & CAO at Quest Diagnostics Inc., a leading company in the medical diagnostics field. In this role, he is responsible for the financial management and regulatory compliance of the company, ensuring transparency and integrity in financial operations.